Goiter epidemiology and demographics

Jump to navigation Jump to search

Goiter Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Goiter from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Goiter epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Goiter epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Goiter epidemiology and demographics

CDC on Goiter epidemiology and demographics

Goiter epidemiology and demographics in the news

Blogs on Goiter epidemiology and demographics

Directions to Hospitals Treating Cushing’s disease

Risk calculators and risk factors for Goiter epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]

Overview

The incidence of goiter is approximately 1400 to 1700 per 100,000 individuals in females and 900 per 100,000 individuals in males, worldwide. The prevalence of goiter is approximately 3000 per 100,000 individuals worldwide, for single thyroid nodules. The frequency of goiter increases in women over 45 years of age. The rate of occurrence of goiter in females is higher than in males by a ratio of 4:1. There is no racial predilection to goiter.

Epidemiology and Demographics

Incidence

  • Worldwide, the incidence of goiter is approximately 1400 to 1700 per 100,000 individuals in females and 900 per 100,000 individuals in males.[1][2][3]

Prevalence

Age

  • Goiter occurs more commonly in women over 45 years of age.[4][7]

Sex

  • The rate of occurrence of goiter in females is higher than that in males by a ratio of 4:1.[8]

Race

  • There is no racial predilection of goiter.

References

  1. VANDER JB, GASTON EA, DAWBER TR (1954). "Significance of solitary nontoxic thyroid nodules; preliminary report". N Engl J Med. 251 (24): 970–3. doi:10.1056/NEJM195412092512403. PMID 13214371.
  2. Freire-Maia, Ademar; Freire-Maia, Dértia Villalba; Morton, Newton E. (1982). "Epidemiology and Genetics of Endemic Goiter". Human Heredity. 32 (3): 176–180. doi:10.1159/000153286. ISSN 1423-0062.
  3. Freire-Maia DV, Freire-Maia A, Schull WJ, Morton NE, Quelce-Salgado A, Lobo LC (1983). "Epidemiology and genetics of endemic goiter. I. Epidemiological aspects". Isr. J. Med. Sci. 19 (1): 11–6. PMID 6832943.
  4. 4.0 4.1 Vanderpump MP (2011). "The epidemiology of thyroid disease". Br. Med. Bull. 99: 39–51. doi:10.1093/bmb/ldr030. PMID 21893493.
  5. Vanderpump, M. P. J. (2011). "The epidemiology of thyroid disease". British Medical Bulletin. 99 (1): 39–51. doi:10.1093/bmb/ldr030. ISSN 0007-1420.
  6. Zimmermann MB (2009). "Iodine deficiency". Endocr Rev. 30 (4): 376–408. doi:10.1210/er.2009-0011. PMID 19460960.
  7. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F (1995). "The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey". Clin. Endocrinol. (Oxf). 43 (1): 55–68. PMID 7641412.
  8. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA (1977). "The spectrum of thyroid disease in a community: the Whickham survey". Clin. Endocrinol. (Oxf). 7 (6): 481–93. PMID 598014.

Template:WH Template:WS